false
OasisLMS
Login
Catalog
OnDemand: Grand Rounds- May 2026: Artificial Intel ...
Artificial Intelligence and the Changing Landscape ...
Artificial Intelligence and the Changing Landscape of Obesity Medicine
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
Dr. Geetanjali Srivastava’s grand rounds talk explored artificial intelligence through the lens of obesity medicine, blending clinical insight, innovation, and personal stories. She framed the presentation around “GOATS” and shared lessons from her father’s forward-thinking research in carbon nanotubes and low-power chip design, connecting it to today’s AI hardware energy challenges. She explained how human thinking differs from AI, emphasizing that obesity care is probabilistic rather than deterministic: treatments shift the chances of outcomes rather than guaranteeing results.<br /><br />Srivastava reviewed the history of AI, from Turing and McCarthy to early chatbots like ELIZA, and outlined how AI systems are built, trained, and tested. She highlighted how AI can reveal heterogeneity in obesity treatment response, support more precise clinical trials, and help determine medication eligibility using existing clinical features. At Vanderbilt, her team is using AI and real-world data to identify care gaps, improve continuity, and reduce discontinuation through patient-centered digital tools.<br /><br />She also discussed the future of agentic AI, wearable integration, ethics, governance, bias mitigation, and clinician-AI collaboration. Her conclusion: AI will not replace obesity specialists, but will amplify them by reducing administrative burden, improving access, and enabling more proactive, personalized care.
Keywords
artificial intelligence
obesity medicine
clinical decision support
machine learning
real-world data
personalized care
wearable technology
AI ethics
patient-centered digital tools
×
Please select your language
1
English